Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
US diabetes patients face delays as insurers tighten Ozempic coverage
Reuters
Tue, 12/12/23 - 10:03 am
Novo Nordisk
type 2 diabetes
Ozempic
insurers
GE HealthCare, Novo Nordisk partner to treat diabetes and obesity with ultrasound
Mass Device
Fri, 10/20/23 - 10:14 am
Medtech
GE Healthcare
Novo Nordisk
PFUS
ultrasound
obesity
type 2 diabetes
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
TheracosBio reports data from trial of diabetes therapy
Clinical Trials Arena
Mon, 08/7/23 - 12:00 pm
TheracosBio
diabetes
type 2 diabetes
Brenzavvy
clinical trials
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
Benzinga
Tue, 06/20/23 - 09:46 pm
Eli Lilly
Boehringer Ingelheim
Jardiance
Synjardy
type 2 diabetes
pediatric
FDA
AstraZeneca drops another GLP-1 after phase 1 data bust market-beating diabetes hopes
Fierce Biotech
Tue, 06/20/23 - 10:15 am
AstraZeneca
GLP-1 agonist
AZD0186
type 2 diabetes
Eli Lilly’s Mounjaro likely to become ‘leading therapy’ for obesity and type 2 diabetes
Biopharma Reporter
Thu, 06/15/23 - 10:06 am
Eli Lilly
Mounjaro
obesity
type 2 diabetes
With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena
Fierce Pharma
Mon, 01/23/23 - 10:52 am
bexaglifozin
diabetes
FDA
Brenzavvy
type 2 diabetes
Theracos
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Endpoints
Fri, 01/13/23 - 11:10 am
Novo Nordisk
Rybelsus
semaglutide
FDA
type 2 diabetes
diabetes
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
Fierce Biotech
Thu, 01/12/23 - 10:39 am
Oramed
diabetes
type 2 diabetes
clinical trials
insulin
oral insulin
ORMD-0801
Lilly and Boehringer's Jardiance Racks Up Another Type 2 Diabetes Win
BioSpace
Wed, 12/7/22 - 11:40 pm
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Jardiance
pediatri
Eli Lilly tightens access to diabetes drug, frustrating some people with obesity
Stat
Wed, 12/7/22 - 10:08 am
Eli Lilly
type 2 diabetes
obesity
Mounjaro
social media
Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025
Fierce Pharma
Tue, 12/6/22 - 09:00 pm
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
obesity
drug manufacturing
Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report
Endpoints
Mon, 11/21/22 - 06:34 pm
Eli Lilly
Mounjaro
diabetes
type 2 diabetes
drug manufacturing
Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics
Medtech Dive
Mon, 11/14/22 - 10:41 am
Medtech
devices
Tandem Diabetes
DexCom
type 2 diabetes
CGM
t:slim X2
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Eli Lilly
Mounjaro
Novo Nordisk
Ozempic
type 2 diabetes
With Lilly's Mounjaro set for stardom, an Alzheimer's win would be 'icing on the cake': analysts
Fierce Pharma
Fri, 09/23/22 - 10:48 am
Eli Lilly
type 2 diabetes
obesity
donanemab
Mounjaro
Alzheimer's disease
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
BioSpace
Thu, 09/22/22 - 10:14 am
Novo Nordisk
clinical trials
type 2 diabetes
diabetes
insulin icodec
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Mon, 08/22/22 - 10:00 am
Novo Nordisk
clinical trials
CagriSema
semaglutide
diabetes
type 2 diabetes
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »